Hexavalent DTaP-HBV-IPV-Hib vaccine (reduced-dose IPV)

Diphtheria, Tetanus, acellular Pertussis, Hepatitis B, Haemophilus influenzae type b, and inactivated Poliovirus vaccine · Serum Institute of India Pvt. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hexavalent DTaP-HBV-IPV-Hib vaccine (reduced-dose IPV), covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV [Phase 3]

See pricing